Back to Search Start Over

A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML.

Authors :
Cole R.
Li J.
Vidacs E.
Rogers A.J.
Kats L.M.
Vervoort S.J.
Nagaraja R.
Yen K.E.
Johnstone R.W.
Gregory G.P.
Cole R.
Li J.
Vidacs E.
Rogers A.J.
Kats L.M.
Vervoort S.J.
Nagaraja R.
Yen K.E.
Johnstone R.W.
Gregory G.P.
Publication Year :
2017

Details

Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.on1305130556
Document Type :
Electronic Resource

Tools

Authors Abstract Subjects Details